in the nonmevalonate pathway of isoprenoid biosynthesis represents a promising strategy for the development of novel antimalarial agents. A small series of reverse hydroxamate‐based fosmidomycin analogues was synthesized and evaluated for their inhibitory activity against the recombinant 1‐deoxy‐D‐xylulose 5‐phosphate reductoisomerases (DXRs) of Escherichia coli and Plasmodium falciparum, as well as
抑制类
异戊二烯生物合成的非甲羟
戊酸途径中涉及的酶代表了开发新型
抗疟药的一种有前途的策略。合成了一小部分基于异羟
肟酸酯的
磷霉素类似物,并评估了它们对大肠杆菌和恶性疟原虫的
重组1-脱氧-D-木酮糖5-
磷酸还原异构酶(DXR)的抑制活性,以及它们的体外抗血浆活性和细胞毒性。